Rainbow Childrens Medicare

1,399.30
-8.40
(-0.60%)
ann
Q4 Quarterly Results are out. Check out the updated financials3 days ago
Viewcross
right
Market Cap
14,295.40 Cr
EPS
21.38
PE Ratio
58.38
Dividend Yield
0.21 %
52 Week High
1,709.60
52 Week Low
1,079.10
PB Ratio
9.68
Debt to Equity
0.58
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from7 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,135.20
#1 1,11,699.10
97.13
5,584.10
18.77
#1 1,058
26.84
48.68
6,923.00
1,00,023.80
76.01
#1 19,165.50
14.74
917
49.14
48.84
716.30
53,647.30
63.88
6,931.20
8.99
645
-7.43
59.99
1,764.80
35,237.90
#1 45.29
5,093.40
10.96
790
3.41
52.86
1,197.10
32,504.40
61.96
2,759.20
#1 25.09
326
-20.35
46.99
541.00
27,108.60
72.73
3,723.70
22.85
205
#1 3,986.36
51.33
649.15
26,083.10
68.97
2,511.20
12.94
336
48.39
50.09
1,399.30
#8 14,295.40
#3 58.38
#9 1,334.00
#9 10.76
#7 218
#5 10.57
55.36
1,443.80
9,486.70
49.02
1,095.50
21.32
177
-0.88
49.12
539.40
7,680.40
168.97
1,929.10
12.97
41
-71.06
41.87
Forecast
Actual
Growth Rate
Revenue Growth
10.76 %
Net Income Growth
2.78 %
Cash Flow Change
-2.24 %
ROE
-13.44 %
ROCE
-15.21 %
EBITDA Margin (Avg.)
-1.52 %

Quarterly Financial Results

Quarterly Financials
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
166
249
271
255
219
243
321
315
326
295
341
345
354
342
429
411
385
Expenses
132
168
177
160
164
155
204
200
219
200
215
218
236
237
270
264
255
EBITDA
34
80
94
95
54
88
117
115
107
96
125
127
118
106
158
148
129
Operating Profit %
20 %
32 %
34 %
36 %
23 %
35 %
35 %
35 %
31 %
31 %
35 %
35 %
31 %
28 %
35 %
34 %
31 %
Depreciation
20
19
21
21
22
22
23
23
23
25
27
28
32
34
35
35
34
Interest
13
13
12
12
16
14
13
14
14
15
13
14
17
18
18
18
18
Profit Before Tax
2
48
61
62
16
52
81
78
70
56
85
85
69
53
105
94
77
Tax
1
12
16
17
4
13
20
20
16
14
22
22
18
14
26
25
20
Net Profit
1
36
45
45
12
39
62
58
54
42
63
63
51
40
79
69
57
EPS in ₹
0.14
3.91
4.87
4.79
1.36
3.78
6.06
5.74
5.31
4.04
6.20
6.12
5.02
3.89
7.77
6.76
5.55

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
Fixed Assets
78
123
174
296
702
702
772
858
931
1,253
Current Assets
98
171
125
73
133
203
197
290
478
622
Capital Work in Progress
35
31
7
12
23
43
29
6
23
20
Investments
7
2
6
0
3
10
18
22
58
308
Other Assets
111
194
212
140
199
265
262
409
759
590
Total Liabilities
231
349
399
448
926
1,019
1,081
1,296
1,771
2,170
Current Liabilities
36
42
56
71
92
130
122
125
139
150
Non Current Liabilities
15
13
14
15
463
480
511
564
567
756
Total Equity
181
295
329
362
372
409
448
606
1,065
1,265
Reserve & Surplus
166
275
309
307
317
351
392
498
958
1,157
Share Capital
15
20
20
55
55
55
55
105
102
102

Cash Flow

Cash Flow
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-1
3
1
-2
2
2
-1
4
7
-7
Investing Activities
-113
-20
-107
-33
-42
-117
-117
-83
-175
-465
-227
Operating Activities
15
26
17
36
48
127
170
143
224
329
321
Financing Activities
98
-7
93
-1
-8
-9
-52
-61
-44
143
-102

Share Holding

% Holding
Dec 2021
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
63.70 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.83 %
49.88 %
49.85 %
49.85 %
49.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
21.63 %
22.32 %
24.04 %
24.78 %
25.11 %
25.12 %
23.69 %
DIIs
0.00 %
6.35 %
6.55 %
10.26 %
13.90 %
15.38 %
15.35 %
15.40 %
15.62 %
14.76 %
13.80 %
13.83 %
13.87 %
15.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
19.03 %
15.87 %
13.24 %
13.75 %
13.29 %
13.04 %
11.92 %
11.03 %
10.40 %
10.74 %
10.40 %
10.38 %
10.34 %
Others
36.30 %
24.79 %
27.75 %
26.67 %
22.52 %
21.50 %
21.78 %
1.22 %
1.21 %
0.97 %
0.80 %
0.80 %
0.77 %
0.79 %
No of Share Holders
146
2,43,189
1,66,064
91,530
79,224
75,611
74,690
79,187
80,471
77,152
78,557
77,524
78,764
79,092

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 2 3 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.28 0.23 0.21 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Jul 2025 1,352.30 1,407.25
28 Jun 2025 DIVIDEND Dividend
₹ 3.00 /share
27 Jun 2025 1,352.30 1,407.25
24 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 May 2025 1,366.75 1,352.30
09 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Feb 2025 1,423.75 1,383.95
27 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
27 Oct 2024 1,431.30 1,417.75
30 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jul 2024 1,393.75 1,172.30
23 Jul 2024 DIVIDEND Dividend
₹ 3.00 /share
23 Jul 2024 1,393.75 1,145.75
22 Jun 2023 DIVIDEND Dividend
₹ 3.00 /share
22 Jun 2023 849.65 977.25
08 Sept 2022 DIVIDEND Dividend
₹ 2.00 /share
07 Sept 2022 489.05 611.60

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome3 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Appointment Of Secretarial Auditor Internal Auditors & Cost Auditors Of The Company5 days ago
The Record Date For Payment Of The Final Dividend Has Been Fixed As June 28 20255 days ago
Announcement under Regulation 30 (LODR)-Dividend Updates5 days ago
Corporate Action-Board approves Dividend5 days ago
Convening Of 27Th AGM Of The Company On July 5 20255 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On May 24 20255 days ago
Audited Financial Results For The Quarter And Financial Year Ended March 31 20255 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 17, 2025
Board Meeting Intimation for Approval Of Audited (Standalone & Consolidated) Financial Results For The Period Ended March 31 2025 And To Consider Recommending Final Dividend If Any.May 17, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 13, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 03, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 04, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 03, 2025
Update On Purchase Of Land Parcels Located In Sector 44 & Sector 56 Of Gurugram Haryana.Mar 01, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 15, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 10, 2025
Integrated Filing (Financial)Feb 10, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2025
Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 09, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 09, 2025
Statement On Deviation Or Variation In Utilisation Of Funds Raised Through Initial Public Offer (IPO)Feb 09, 2025
Approval Of Rainbow Childrens Medicare Limited - Employee Stock Option Scheme 2025Feb 09, 2025
Un-Audited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 09, 2025
Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On February 9 2025Feb 09, 2025
Appointment of Company Secretary and Compliance OfficerFeb 09, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 01, 2025
Board Meeting Intimation for Approving The Quarterly Results And Other Business MattersFeb 01, 2025
Announcement under Regulation 30 (LODR)-Credit RatingJan 07, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementDec 13, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerDec 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 12, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 11, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 28, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportOct 27, 2024
Disclosure Under Regulation 30(5) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015Oct 27, 2024

Technical Indicators

RSI(14)
Neutral
55.36
ATR(14)
Less Volatile
40.66
STOCH(9,6)
Neutral
66.68
STOCH RSI(14)
Overbought
95.72
MACD(12,26)
Bullish
6.06
ADX(14)
Weak Trend
11.52
UO(9)
Bearish
58.39
ROC(12)
Uptrend But Slowing Down
2.90
WillR(14)
Neutral
-21.88

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
HSBC Focused Fund Direct - Growth
150000
1.31%
-1.39%
-2.09%
Apr 2025
Bandhan Focused Equity Fund Direct-Growth
0
0.00%
-1.27%
-1.19%
Apr 2025
HSBC Consumption Fund Direct - Growth
181961
1.69%
-0.86%
-0.70%
Apr 2025
SBI Equity Savings Fund Direct-Growth
266056
0.68%
-0.12%
-0.05%
Apr 2025
SBI Long Term Advantage Fund Series III Direct Growth
15000
2.97%
-0.10%
0.05%
Apr 2025
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0
0.00%
-0.10%
-0.09%
Apr 2025
Baroda BNP Paribas Multi Cap Fund Direct-Growth
374094
1.91%
-0.09%
0.11%
Apr 2025
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
29096
1.25%
-0.09%
0.03%
Apr 2025
PGIM India Healthcare Fund Direct-Growth
15035
1.93%
-0.09%
0.27%
Apr 2025
DSP Small Cap Direct Plan-Growth
1536915
1.49%
0.08%
0.24%
Apr 2025
DSP India T.I.G.E.R. (The Infrastructure Growth and Economic Reforms Fund) Direct-Growth
935870
2.61%
-0.08%
1.64%
Apr 2025
SBI Healthcare Opportunities Fund Direct Plan-Growth
640000
2.41%
-0.07%
0.02%
Apr 2025
DSP Aggressive Hybrid Fund Direct-Growth
1007153
1.29%
-0.06%
0.26%
Apr 2025
Motilal Oswal Small Cap Fund Direct - Growth
828224
2.64%
-0.06%
-0.04%
Apr 2025
Baroda BNP Paribas ELSS Tax Saver Fund Direct-Growth
100860
1.57%
-0.06%
0.03%
Apr 2025
Bajaj Finserv Healthcare Fund Direct-Growth
45941
2.04%
-0.05%
0.43%
Apr 2025
Nippon India Equity Hybrid Fund Direct-Growth
248655
0.90%
-0.05%
0.03%
Apr 2025
ITI Pharma and Healthcare Fund Direct - Growth
20150
1.27%
-0.05%
0.28%
Apr 2025
Axis Flexi Cap Fund Direct-Growth
770362
0.86%
-0.04%
0.00%
Apr 2025
WhiteOak Capital Multi Cap Fund Direct - Growth
36273
0.29%
-0.04%
-0.03%
Apr 2025
DSP Flexi Cap Fund Direct Plan-Growth
955787
1.16%
-0.04%
0.01%
Apr 2025
PGIM India Small Cap Fund Direct - Growth
151386
1.50%
-0.04%
0.03%
Apr 2025
WhiteOak Capital ESG Best-In-Class Strategy Fund Direct-Growth
2719
0.60%
-0.04%
0.02%
Apr 2025
WhiteOak Capital Equity Savings Fund Direct - Growth
294
0.08%
-0.04%
0.08%
Apr 2025
Nippon India Nifty 500 Equal Weight Index Fund Direct-Growth
5139
0.18%
-0.03%
-0.02%
Apr 2025

About Rainbow Childrens Medicare

Rainbow Children's Medicare Limited is a leading chain of multi-specialty pediatric, obstetrics, and gynecology hospitals in India. Originally incorporated in 1998, it operates 16 hospitals and three clinics across six cities, with a total bed capacity of 1,655. The company specializes in pediatric services, including newborn and pediatric intensive care, multi-specialty services, and quaternary care, as well as obstetrics and gynecology services. Founded by Dr. Ramesh Kancharla, Rainbow follows a full-time, exclusive doctor-led model of healthcare delivery. The company expanded its services over the years, establishing hospitals in various cities and introducing new specialties. In 2022, Rainbow completed an Initial Public Offering and its shares were listed on the National Stock Exchange of India Limited and BSE Limited. The company also offers post-graduate DNB and fellowship programs in pediatrics.
Listing Date
10 May, 2022(3 Years, 20 days)
Chairperson NameRamesh Kancharla